Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen BioNTech SE stake
total: 670
Viking Global Investors BNTX trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2024 Q3
- Held for:
- 3 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any BioNTech SE (BNTX) shares. To date, the estimated cost basis is nearly $114.19 for "buy" trades and estimated average "sell" price is $91.06. Viking Global Investors first purchased BNTX in 2024 Q3, initially acquiring 46,294 shares. Since the initial investment in BioNTech SE (BNTX), Viking Global Investors has made 3 more transactions.
When did Ole Andreas Halvorsen sell BioNTech SE (BNTX)?
Ole Andreas Halvorsen sold off the entire BioNTech SE (BNTX) position in 2025 Q2.
When did Ole Andreas Halvorsen buy BioNTech SE (BNTX)?
Ole Andreas Halvorsen first invested in BioNTech SE (BNTX) in 2024 Q3 at the reported quarter-end price of $118.77 per share.
What's the cost basis of Viking Global Investors's BNTX stake?
The estimated cost basis for BioNTech SE (BNTX) stake is around $114.19 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $114.19
- Weighted AVG sell price:
- $91.06
Ole Andreas Halvorsen's historical trades in BioNTech SE
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$91.06
|
|
-100% (-879,972)
|
-0.25%
|
|
2025 Q1
|
0.25%
|
879,972
|
$91.06
|
$80,130,250
|
-6.47% (-60,878)
|
-0.02%
|
|
2024 Q4
|
0.35%
|
940,850
|
$113.95
|
$107,209,858
|
+1,932.34% (+894,556)
|
+0.33%
|
|
2024 Q3
|
0.02%
|
46,294
|
$118.77
|
$5,498,338
|
new
|
+0.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.